InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (23 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
23
T+90 hit rate
50%
T+90 mean return
-8.0%
Across 8 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Leonard Frank X, Directeur du Développement. Officer active across 1 company, notably NovoCure Ltd. In total, 36 filings have been published. Split: 0 buy · 23 sells. Total volume traded: €5.1m. Activity tracked since 6 July 2021. The latest transaction was filed on 3 March 2026 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Declarations36 total
150,000 shares0Ordinary SharesSEC:0001822879-26-000003:0
9,734 shares@ US$13.6638Ordinary SharesSEC:0001822879-26-000002:0
966 shares@ US$12.810.1% of flowOrdinary SharesSEC:0001822879-25-000006:0
833 shares@ US$15.130.1% of flowOrdinary SharesSEC:0001562180-25-005188:0
179,426 shares0Ordinary SharesSEC:0001562180-25-004553:0
21,717 shares@ US$17.21964.3% of flowOrdinary SharesSEC:0001562180-25-004426:0
54,975 shares@ US$18.1912.8% of flowOrdinary SharesSEC:0001562180-25-002159:0
2,527 shares@ US$18.53630.6% of flowOrdinary SharesSEC:0001562180-25-001976:0
10,277 shares@ US$19.92192.6% of flowOrdinary SharesSEC:0001562180-25-001915:0
10,277 shares@ US$19.92192.6% of flowOrdinary SharesSEC:0001562180-25-001834:0
598 shares@ US$15.93770.1% of flowOrdinary SharesSEC:0001562180-24-007516:0
1,736 shares@ US$12.240.3% of flowOrdinary SharesSEC:0001562180-24-006039:0
1,679 shares@ US$16.02690.3% of flowOrdinary SharesSEC:0001562180-24-002247:0
102,249 shares@ US$16.3020.7% of flowOrdinary SharesSEC:0001562180-24-001988:0
4,403 shares@ US$76.15944.3% of flowOrdinary SharesSEC:0001562180-23-002581:0
844 shares@ US$75.27790.8% of flowOrdinary SharesSEC:0001562180-23-002489:0
3,799 shares@ US$75.32353.6% of flowOrdinary SharesSEC:0001562180-23-002359:0
18,621 shares0Ordinary SharesSEC:0001645113-23-000031:0
2,345 shares@ US$119.00773.5% of flowOrdinary SharesSEC:0001645113-23-000009:0
6,830 shares0Ordinary SharesSEC:0001645113-22-000093:0
6,754 shares@ US$76.017.1% of flowOrdinary SharesSEC:0001645113-22-000086:0
6,754 shares@ US$84.377.8% of flowOrdinary SharesSEC:0001645113-22-000085:0
6,754 shares@ US$77.357.2% of flowOrdinary SharesSEC:0001645113-22-000084:0
6,754 shares@ US$77.007.1% of flowOrdinary SharesSEC:0001645113-22-000083:0
5,517 shares@ US$7.150.5% of flowOrdinary SharesSEC:0001645113-22-000082:0
25 of 36 declarations
About Leonard Frank X
Frank X. Leonard is the Chief Development Officer at NovoCure Ltd. He is responsible for leading the company's development initiatives, focusing on innovation and product expansion. His expertise is crucial for NovoCure's growth strategy.
